Your selection
Innovation / 06.06.2025
Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany
Eckert & Ziegler (ISIN DE0005659700, SDAX) congratulates Telix Pharmaceuticals Limited (Telix) on the approval of its prostate cancer PET imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection) in Germany, where Eckert & Ziegler Radiopharma GmbH is the official distributor.
With Illuccix®, Eckert & Ziegler will now significantly extend its portfolio in nuclear medicine with a widely clinically validated PSMA tracer, which perfectly complements its proprietary 68Ge/68Ga Radionuclide Generator, GalliaPharm®. GalliaPharm® is widely used as a high-quality GMP grade generator for Gallium-68 in Germany and globally, supporting the production of radiopharmaceuticals for positron emission tomography (PET) imaging, particularly in oncology.
"Our collaboration with Telix on Illuccix® leverages our established distribution network and market expertise to ensure broad access to this important PSMA-PET imaging agent in Germany. This partnership reinforces our commitment to delivering advanced diagnostic solutions for prostate cancer care", commented Dr. Harald Hasselmann, CEO of Eckert & Ziegler SE.
Raphaël Ortiz, Chief Executive Officer, Telix International added: “We are pleased that Illuccix®, which has played a key role in the advancement of PSMA-PET imaging internationally, has been approved in Germany. We are looking forward to working with Eckert & Ziegler to make our gallium-based PSMA-PET imaging agent accessible here.”
About Eckert & Ziegler
Eckert & Ziegler SE, with more than 1,000 employees, is a leading specialist in isotope-related components for nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
Source: Press Release Eckert & Ziegler
Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany
Overview News
News Buch Berlin
Berlin honors outstanding deep-tech companies—including MyoPax
This year, for the first time, a Deep Tech Award was presented in the Bio & Health Tech category. The winner is MyoPax, a spin-off of the Max Delbrück Center and Charité.
more ...Eckert & Ziegler Receives “Best Managed Companies Award” Once Again
Eckert & Ziegler SE (ISIN DE0005659700) has won the “Best Managed Companies Award” for the third time in a row. With this honor, Deloitte Private, UBS, Frankfurter Allgemeine Zeitung, and the Federati...
more ...Eckert & Ziegler with a Successful Start to the Year. 2026 Forecast Confirmed.
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) increased its sales in the first quarter of 2026 by 7% to €72.9 million compared with the same period last year.
more ...Events Buch Berlin
18.06.2026, 11:00
Einladung zum Tag der offenen Tür - „Room of Horror“ statt Langeweile
Die Akademie der Gesundheit e.V. öffnet am Campus Berlin-Buch ihre Tore und zeigt, dass Ausbildung auch „Room of Horror“, OP-Action und High-Tech-Simulation bedeuten kann.
more ...19.06.2026, 18:30
Benefizkonzert für die Sanierung der barocken Schlosskirche Berlin-Buch
Magdalena Pflüger spielt Werke von Beethoven, Schumann, Rachmaninow und Schostakowitsch
more ...20.06.2026, 14:00
Gauklerfest auf der Moorwiese
Der Archäologie- und Abenteuerspielplatz lädt wieder zum Gauklerfest ein
more ...
